Login to Your Account

Blackthorn secures $40M series A, seeks to pierce neurobehavioral field

By Marie Powers
News Editor

Friday, October 21, 2016

Quietly launched three years ago, Blackthorn Therapeutics Inc. declared its intention to tackle neurobehavioral disorders in a big way, closing a $40 million series A.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription